Insider Shareholders with Direct Ownership of Acrivon Therapeutics, Inc. (ACRV)
This section provides a comprehensive overview of the insiders with direct ownership of Acrivon Therapeutics, Inc. (ACRV). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Acrivon Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Chione Ltd
> 10% Shareholder |
3,856,597 | 7,965 | 3,848,632 | 6 |
Jun 26, 2023
Reduced 0.0%
|
|
Peter Blume Jensen
President and CEO |
2,025,839 | 554,859 | 2,342,837 | 10 |
Nov 21, 2024
Reduced 0.84%
|
| 888,130 | 0 | 888,130 | 1 |
Nov 17, 2022
Added 50.0%
|
|
|
Kristina Masson
EVP - Business Operations |
26,707 | 3,459 | 317,246 | 5 |
Aug 14, 2024
Reduced 0.15%
|
|
Eric Devroe
Chief Operating Officer |
52,608 | 5,012 | 67,871 | 8 |
Nov 14, 2024
Reduced 0.9%
|
|
Mary Miller
Chief Legal Officer |
3,858 | 6,346 | 37,941 | 12 |
Nov 14, 2024
Reduced 0.48%
|
|
Rasmus Holm Jorgensen
Chief Financial Officer |
29,530 | 3,008 | 26,522 | 7 |
Nov 14, 2024
Reduced 1.37%
|
|
Erick Gamelin
Chief Development Officer |
20,030 | 3,069 | 16,961 | 6 |
Nov 14, 2024
Reduced 2.32%
|
|
Katharine Peterson
Chief Accounting Officer |
0 | 297 | 4,535 | 3 |
Nov 14, 2024
Reduced 2.14%
|